Company Filing History:
1 out of 5 
1 out of 2 
1 out of 24 
Years Active: 2005-2016
Title: The Innovations of Benjamin Joseph Rankin
Introduction
Benjamin Joseph Rankin is a notable inventor based in York, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of metal compounds for medical use. With a total of three patents to his name, Rankin's work focuses on addressing critical health issues such as hyperphosphataemia.
Latest Patents
Rankin's latest patents include innovative metal compounds mixed or sulphated, designed as phosphate binders. These mixed metal compounds are free from aluminum and possess a phosphate binding capacity of at least 30% by weight of the total phosphate present, across a pH range of 2-8. This compound is particularly beneficial for the treatment of hyperphosphataemia. The preferred metals used in these compounds are iron (III) along with calcium, magnesium, lanthanum, and cerium. Additionally, he has developed a metal sulphate for pharmaceutical use, selected from calcium, lanthanum, and cerium sulphate compounds, which also demonstrates a phosphate binding capacity of at least 30% by weight over the same pH range.
Career Highlights
Throughout his career, Rankin has worked with prominent companies such as Ineos Silicas Limited and Cytochroma Development Inc. His experience in these organizations has contributed to his expertise in the development of pharmaceutical innovations.
Collaborations
Rankin has collaborated with notable individuals in his field, including Norman Bryson Roberts and Maurice Webb. These partnerships have likely enhanced his research and development efforts.
Conclusion
Benjamin Joseph Rankin's contributions to pharmaceutical innovations, particularly in the area of phosphate binders, highlight his role as a significant inventor in the medical field. His work continues to impact the treatment of critical health conditions.